Association Briefs

The Merger That Didn’t Happen After months of discussions, plans for a merger of the nation’s two largest biotechnology associations have fallen through. The Industrial Biotechnology Association had proposed joining forces with the Association of Biotechnology Companies in July. In discussions that went on through the summer, the two Washington-based organizations couldn’t resolve questions about equal representation of their members, according to the ABC’s new executiv

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After months of discussions, plans for a merger of the nation’s two largest biotechnology associations have fallen through. The Industrial Biotechnology Association had proposed joining forces with the Association of Biotechnology Companies in July. In discussions that went on through the summer, the two Washington-based organizations couldn’t resolve questions about equal representation of their members, according to the ABC’s new executive director, Pamela Bridgen. Although there is some overlapping between the two groups, IBA’s member companies tend to be larger and pay higher dues than those in the ABC, which also includes noncorporate groups like universities and independent institutes. The ABC has now proposed a “Biotechnology Association’s Roundtable,” which would meet quarterly to review biotechnology issues and plan strategy, but Richard Godown, the IBA president, says the idea “seems improbable at this time" and suggested that the ABC’s rejection of the merger will likely mean less collaboration. Although both groups ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies